Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Real‐world weight‐loss effectiveness of glucagon‐like peptide‐1 agonists among patients with type 2 diabetes: A retrospective cohort study

Obesity(2023)10.1002/oby.23622Source: DataRank Database

Real‐world weight‐loss effectiveness of glucagon‐like peptide‐1 agonists among patients with type 2 diabetes: A retrospective cohort study is a research paper published in Obesity (2023). On theSindex it has a DataRank of 0. It has been cited 62 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access62 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 10.25)OA: bronzeTopics (47)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Ingrid Shu,David Rometo,Jon A. Arnold,Mary T. Korytkowski ORCID,Jing Luo ORCID

Live enrichment

PubMed:36621904 PMC:PMC9877131 OpenAlex:https://openalex.org/W4313880066

National Center for Advancing Translational Sciences

Grant: KL2TR001856

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: K23DK120956

FWCI

10.25

Citation Percentile

1.0%

Influential Citations

Citation Trend

2022

2023

2024

2025

2026

bronzeLicense: http://onlinelibrary.wiley.com/termsAndConditions#vor

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/oby.23622

GREENhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877131

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/oby.23622

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/oby.23622

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/oby.23622

Fields of Study

Diabetes Treatment and ManagementBariatric Surgery and OutcomesHyperglycemia and glycemic control in critically ill and hospitalized patientsMedicineAdultHumansFemaleMiddle AgedMaleDiabetes Mellitus, Type 2Hypoglycemic AgentsRetrospective StudiesGlycated HemoglobinWeight LossBody WeightGlucagon-Like Peptide 1Glucagon-Like Peptide-1 Receptor

MeSH Terms

Glucagon-Like Peptide-1 ReceptorAdultBody WeightDiabetes Mellitus, Type 2FemaleGlycated HemoglobinHumansHypoglycemic AgentsMaleMiddle AgedRetrospective StudiesWeight LossGlucagon-Like Peptide 1

Keywords

MedicineWeight lossType 2 diabetesGlucagon-like peptide-1Retrospective cohort studyCohortAgonistBody weightInternal medicineDiabetes mellitusGlucagonEndocrinologyGlucagon-like peptide 1 receptorCohort studyObesityInsulinReceptor

Sustainable Development Goals

SDG 0: Good health and well-being